FROST PHILLIP MD ET AL purchased $10K of COCP (indirect holdings)
FROST PHILLIP MD ET AL purchased 10,000 indirectly-held shares of Cocrystal Pharma, Inc. (COCP) at $0.98 on 2026-08-05.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market purchase size, price, and date by a director/10% owner via indirect holdings, without any accompanying company news.
Market read
Traders may note the insider buy as a minor sentiment input, but there is no fundamental update in the text.
What to watch
No 10b5-1 plan is stated, but the filing does not disclose intent, timing constraints, or whether the buyer’s broader position is changing materially beyond the post-transaction share count.
Background
This is an SEC Form 4 insider transaction disclosure for Cocrystal Pharma, Inc.
Ticker impact
Cocrystal Pharma disclosed a Form 4 showing a director and 10% owner bought 10,000 shares at $0.9816 on 2026-08-05 via indirect holdings.
Low near-term impact; any effect is likely sentiment-driven and limited to microcap liquidity.
Form 4 insider buys can be read as confidence signals, but the disclosed value ($9,816) is modest and the article provides no accompanying operational or financial catalyst.
Market effects
No sector read-through is provided beyond a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
The purchase is indirect and small, so it may reflect routine liquidity management or non-informational factors rather than a bullish thesis.
Key entities
- issuerCocrystal Pharma, Inc.
Subject of the Form 4 insider transaction disclosure (COCP).
- insiderFrost Phillip MD et al
Director and 10% owner reporting an indirect open-market purchase of 10,000 shares.